Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Abstract 668: The translational biology of small molecule GPR65 inhibitors: shared effects between mouse models and human primary tumors highlight the unique transformative potential of targeting a genetically validated innate immune checkpoint

Cipriani B. et al, (2023), Cancer Research, 83, 668 - 668

Deep sequencing of the T cell Receptor reveals common and reproducible CD8+signatures of response to checkpoint immunotherapy

Watson RA. et al, (2023)

Ibex: Variational autoencoder for single-cell BCR sequencing

Borcherding N. et al, (2022)

Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.

Spagni G. et al, (2022), J Neurol Neurosurg Psychiatry

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19

Kotanidis CP. et al, (2022), The Lancet Digital Health, 4, e705 - e716

Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders

Damato V. et al, (2022), Proceedings of the National Academy of Sciences, 119

Dissecting the autoantibody repertoire in CASPR2-antibody encephalitis

Sun B. et al, (2022), Journal of Neurology, Neurosurgery & Psychiatry, 93, A4.1 - A4

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Peng Y. et al, (2021), Nature Immunology

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2021)

Double-jeopardy: scRNA-seq doublet/multiplet detection using multi-omic profiling

Sun B. et al, (2021), Cell Reports Methods, 100008 - 100008

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort

Cross H. et al, (2021), Frontiers in Neurology, 11

Double-Jeopardy: scRNA-seq Doublet/Multiplet Detection Using Multi-Omic Profiling

Sun B. et al, (2020), SSRN Electronic Journal

The B cell immunobiology that underlies CNS autoantibody-mediated diseases

Sun B. et al, (2020), Nature Reviews Neurology, 16, 481 - 492

Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms

Ramberger M. et al, (2020), Brain, 143, 1731 - 1745

Immunological mechanisms for the efficacy of Rituximab in aquaporin-4 autoantibody mediated Neuromyelitis Optica spectrum disorders

Damato V. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 74 - 74

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

Waters P. et al, (2020), JAMA Neurology, 77, 82 - 82

A TUMULTUOUS CASE OF EPISODIC APNOEA

Sun B. et al, (2019), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, E15 - E15

Teratoma-derived glycine receptor antibodies in progressive encephalomyelitis with rigidity and myoclonus

(2019), European Journal of Neurology

Serial MOG-antibody analyses and outcomes in a prospective unselected cohort of pediatric demyelinating syndromes

WATERS P. et al, (2019), JAMA Neurology

Load More

Include forthcoming?